This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Venlafaxine Hydrochloride

Read time: 1 mins
Marketing start date: 23 Dec 2024
...
 

Summary of product characteristics


Effective Time

20230519

Version

1

Spl Product Data Elements

Venlafaxine Hydrochloride Venlafaxine Hydrochloride VENLAFAXINE HYDROCHLORIDE VENLAFAXINE ETHYLCELLULOSE (7 MPA.S) FERROSOFERRIC OXIDE GELATIN HYPROMELLOSE 2910 (15 MPA.S) HYPROMELLOSE 2910 (5 MPA.S) MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL 8000 POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC SODIUM LAURYL SULFATE TALC TITANIUM DIOXIDE WATER grey opaque colored cap white opaque colored body ZA;35;37;5;mg Venlafaxine Hydrochloride Venlafaxine Hydrochloride VENLAFAXINE HYDROCHLORIDE VENLAFAXINE ETHYLCELLULOSE (7 MPA.S) FERRIC OXIDE RED FERROSOFERRIC OXIDE GELATIN HYPROMELLOSE 2910 (15 MPA.S) HYPROMELLOSE 2910 (5 MPA.S) MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL 8000 POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC SODIUM LAURYL SULFATE TALC TITANIUM DIOXIDE WATER peach opaque colored cap white opaque colored body ZA;36;75;mg Venlafaxine Hydrochloride Venlafaxine Hydrochloride VENLAFAXINE HYDROCHLORIDE VENLAFAXINE ETHYLCELLULOSE (7 MPA.S) FERRIC OXIDE RED FERROSOFERRIC OXIDE GELATIN HYPROMELLOSE 2910 (15 MPA.S) HYPROMELLOSE 2910 (5 MPA.S) MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL 8000 POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC SODIUM LAURYL SULFATE TALC TITANIUM DIOXIDE WATER dark orange opaque colored cap white opaque colored body ZA;37;150;mg

Application Number

ANDA090174

Brand Name

Venlafaxine Hydrochloride

Generic Name

Venlafaxine Hydrochloride

Product Ndc

70771-1837

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1836-9 Venlafaxine Hydrochloride Extended-release Capsules USP, 37.5 mg 90 Capsules Rx only NDC 70771-1837-9 Venlafaxine Hydrochloride Extended-release Capsules USP, 75 mg 90 Capsules Rx only NDC 70771-1838-9 Venlafaxine Hydrochloride Extended-release Capsules USP, 150 mg 90 Capsules Rx only 37.5 mg label 75 mg label 150 mg label

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.